RecruitingNCT06621810

Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

AI-MEL: Image Analysis and Machine Learning for Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults


Sponsor

German Cancer Research Center

Enrollment

3,000 participants

Start Date

Dec 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to develop supportive diagnostic artificial intelligence algorithms to distinguish melanoma from nevi or other benign pigmented skin lesions, especially in younger patients (below the age of 30). The main goals it aims to achieve are: * development of an algorithm based on dermatoscopic images, targeting skin cancer screening in vulnerable populations * development of another algorithm based on histological images, intended to be used by pathologists on lesions that are still suspicious of melanoma after dermatologic assessment * implementation of explainability methods to enable the user to better comprehend the systems' decisions, avoid biases and increase trust in these applications There is no additional time commitment for the study participants for this study, as the data used in this project will be collected in routine clinical practice anyway.


Eligibility

Inclusion Criteria1

  • \-

Exclusion Criteria2

  • Patients without a melanoma or nevus diagnosis
  • images with insufficient image quality

Locations(3)

University of Tübingen

Tübingen, Germany

University of Florence

Florence, Italy

Hospital Clínic de Barcelona

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06621810


Related Trials